| Utestående aktier | 278,291,590 shares |
| Insideraktier | 93 665 391 shares |
| Insynsägande | 33,66 % |
| Totalt antal insynspersoner | 23 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
5373 out of 10786
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Sana Biotechnology, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Noubar Afeyan
10% Owner -
|
11 585 199 | 0 | |
| Sunil Agarwal EVP, Head of Development & CMO - [O] | 1 550 000 | 1 550 000 | |
|
ARCH Venture Fund X, L.P.
10% Owner -
|
22 747 272 | 22 747 272 | |
|
ARCH Venture Partners X, LLC
10% Owner -
|
11 718 750 | 22 747 272 | |
| Bilenker Joshua H. Director - [D] | 20 000 | 20 000 | |
| Hans Edgar Bishop Director - [D] | 5 848 503 | 5 848 503 | |
|
Keith Crandell
10% Owner -
|
22 747 272 | 22 747 272 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Bernard J Cassidy EVP & General Counsel - [O] | 112 990 | 112 990 | |
|
FMR LLC / Fidelity Management & Research
10% Owner -
|
4 541 572 | 4 541 572 | |
|
Flagship Ventures Fund V General Partner LLC
10% Owner -
|
22 546 725 | 0 | |
|
Flagship Ventures Management, Inc.
10% Owner -
|
0 | 0 | |
|
Steven Gillis
10% Owner -
|
11 718 750 | 22 747 272 | |
| Nathan Hardy SVP, Chief Financial Officer - [O] | 511 250 | 511 250 | |
| Steve Harr President & CEO, Director - [D] [O] | 7 944 251 | 7 944 251 | |
| Christian Hordo EVP, Chief Business Officer - [O] | 867 455 | 867 455 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| MacDonald James J. EVP & General Counsel - [O] | 497 396 | 497 396 | |
| Richard Mulligan Director - [D] | 2 698 121 | 2 698 121 | |
|
Robert Nelsen
Director, 10% Owner -
[D]
|
22 761 125 | 22 761 125 | |
| Dhavalkumar Dhirajlal Patel EVP, Chief Scientific Officer - [O] | 99 510 | 99 510 | |
| Mary Agnes Wilderotter Director - [D] | 7 106 | 7 106 | |
| Wyrick Susan D. See Remarks - [O] | 196 196 | 196 196 | |
| Patrick Y Yang Director - [D] | 149 250 | 149 250 | |
| Maltzahn Geoffrey von Director - [D] | 366 122 | 366 122 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SANA / Sana Biotechnology, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SANA / Sana Biotechnology, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 | 2026-04-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 763 | 5 848 503 | ||||||
| 2026-03-27 | 3 | PATEL DHAVALKUMAR DHIRAJLAL | SANA | Common Stock | D | 99 510 | ||||||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3,1000 | −12 819 | −40 | 7 944 251 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Harr Steve | SANA | Common Stock | D | 3,1300 | −11 526 | −36 | 7 957 070 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50 000 | 7 968 596 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Harr Steve | SANA | Common Stock | D | 41 666 | 7 918 596 | ||||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,1000 | −1 045 | −3 | 196 196 | ||||
| 2026-03-10 | 2026-03-09 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,1300 | −3 342 | −10 | 197 241 | ||||
| 2026-03-10 | 2026-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 250 | 200 583 | ||||||
| 2026-03-10 | 2026-03-06 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 416 | 197 333 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3,9100 | −491 | −2 | 186 917 | ||||
| 2026-03-04 | 2026-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1 525 | 187 408 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 157 | 5 840 740 | ||||||
| 2026-01-06 | 2026-01-05 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4,2700 | −2 407 | −10 | 185 883 | ||||
| 2026-01-06 | 2026-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 7 500 | 188 290 | ||||||
| 2025-12-16 | 2025-12-15 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5,2200 | −873 | −5 | 180 790 | ||||
| 2025-12-16 | 2025-12-13 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 400 | 181 663 | ||||||
| 2025-12-05 | 2025-12-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 4,4400 | −2 565 | −11 | 178 263 | ||||
| 2025-12-05 | 2025-12-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 000 | 180 828 | ||||||
| 2025-12-05 | 2025-06-04 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,3200 | −2 567 | −6 | 167 828 | ||||
| 2025-12-05 | 2025-06-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 10 000 | 170 395 | ||||||
| 2025-10-07 | 2025-10-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5 628 | 5 834 583 | ||||||
| 2025-07-08 | 2025-07-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 842 | 5 828 955 | ||||||
| 2025-04-08 | 2025-04-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 16 339 | 5 821 113 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Harr Steve | SANA | Common Stock | D | 2,5600 | −12 820 | −33 | 7 876 930 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Harr Steve | SANA | Common Stock | D | 50 000 | 7 889 750 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 2,5600 | −2 833 | −7 | 112 990 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Cassidy Bernard J | SANA | Common Stock | D | 11 041 | 115 823 | ||||||
| 2025-03-10 | 2025-03-10 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,5600 | −836 | −2 | 157 395 | ||||
| 2025-03-10 | 2025-03-07 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 3 250 | 158 231 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 2,5600 | −490 | −1 | 154 981 | ||||
| 2025-03-03 | 2025-03-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1 525 | 155 471 | ||||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 7,2600 | −1 000 | −7 | 4 541 511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,7100 | −164 912 | −1 107 | 4 542 511 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,5000 | −25 000 | −162 | 4 707 423 | ||||
| 2025-01-10 | 2025-01-08 | 4 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 6,1100 | −100 000 | −611 | 4 732 423 | ||||
| 2025-01-07 | 2025-01-06 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 14 285 | 5 804 774 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 1,6500 | −1 566 | −3 | 153 946 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Wyrick Susan D. | SANA | Common Stock | D | 5 000 | 155 512 | ||||||
| 2024-11-21 | 3/A | FMR LLC / Fidelity Management & Research FMR Capital, Inc. | SANA | Common Stock | I | 61 | ||||||||
| 2024-10-15 | 3 | Wyrick Susan D. | SANA | Common Stock | D | 147 512 | ||||||||
| 2024-10-09 | 2024-10-07 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 5 938 | 5 790 489 | ||||||
| 2024-09-26 | 2024-09-25 | 4 | Mulligan Richard | SANA | Common Stock | D | 3,8878 | −150 000 | −583 | 2 698 121 | ||||
| 2024-09-26 | 2024-09-24 | 4 | Mulligan Richard | SANA | Common Stock | D | 4,0838 | −150 000 | −613 | 2 848 121 | ||||
| 2024-07-08 | 2024-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 911 | 5 784 551 | ||||||
| 2024-04-08 | 2024-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 774 | 5 779 640 | ||||||
| 2024-04-08 | 3 | FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP | SANA | Common Stock | I | 4 832 423 | ||||||||
| 2024-03-11 | 2024-03-08 | 4 | Yang Patrick Y | SANA | Common Stock | D | 9,4520 | −25 000 | −236 | 149 250 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | CRANDELL KEITH | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 727 272 | 4 000 | 12 446 022 | ||||
| 2024-02-12 | 2024-02-08 | 4 | ARCH Venture Fund X, L.P. | SANA | Common Stock | I | 5,5000 | 363 637 | 2 000 | 10 667 387 | ||||
| 2024-01-08 | 2024-01-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1 470 | 7 106 | ||||||
| 2024-01-08 | 2024-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 901 | 5 776 866 | ||||||
| 2023-12-18 | 2023-12-15 | 4 | Hordo Christian | SANA | Common Stock | D | 4,0013 | −75 000 | −300 | 867 455 | ||||
| 2023-10-06 | 2023-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 925 | 5 771 965 | ||||||
| 2023-10-06 | 2023-10-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2 077 | 5 636 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC | SANA | Common Stock | I | −70 813 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P. | SANA | Common Stock | I | −2 431 281 | 7 293 841 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC | SANA | Common Stock | I | −1 181 745 | 0 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | −345 069 | 1 035 208 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | −4 926 378 | 8 057 470 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC | SANA | Common Stock | I | −2 825 989 | 8 615 337 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 1 245 | 3 559 | ||||||
| 2023-07-06 | 2023-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 152 | 5 765 040 | ||||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,2397 | −22 760 | −142 | 1 380 277 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,2397 | −177 240 | −1 106 | 10 743 293 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,3061 | −22 297 | −141 | 1 403 037 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,3061 | −181 461 | −1 144 | 10 920 533 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,2265 | −9 330 | −58 | 1 425 334 | ||||
| 2023-05-26 | 2023-05-26 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,2265 | −72 670 | −452 | 11 101 994 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,3522 | −13 127 | −83 | 1 434 664 | ||||
| 2023-05-26 | 2023-05-25 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,3522 | −102 245 | −649 | 11 174 664 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. | SANA | Common Stock | I | 6,5652 | −39 580 | −260 | 1 447 791 | ||||
| 2023-05-26 | 2023-05-24 | 4 | Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. | SANA | Common Stock | I | 6,5652 | −308 290 | −2 024 | 11 276 909 | ||||
| 2023-04-06 | 2023-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 7 716 | 5 760 888 | ||||||
| 2023-04-06 | 2023-04-05 | 4 | Wilderotter Mary Agnes | SANA | Common Stock | D | 2 314 | 2 314 | ||||||
| 2023-02-17 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Common Stock | D | 25,0000 | 20 000 | 500 | 20 000 | ||||
| 2023-01-06 | 2023-01-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 6 702 | 5 753 172 | ||||||
| 2023-01-06 | 2023-01-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 536 | 1 353 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 321 | 817 | ||||||
| 2022-10-06 | 2022-10-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 4 012 | 5 746 470 | ||||||
| 2022-09-20 | 3/A | Cassidy Bernard J | SANA | Common Stock | D | 92 781 | ||||||||
| 2022-09-16 | 3 | Cassidy Bernard J | SANA | Common Stock | D | 82 031 | ||||||||
| 2022-07-07 | 2022-07-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 3 328 | 5 742 458 | ||||||
| 2022-07-07 | 2022-07-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 266 | 496 | ||||||
| 2022-06-15 | 2022-06-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 1,4800 | 66 796 | 99 | 497 396 | ||||
| 2022-06-15 | 2022-05-13 | 4 | MacDonald James J. | SANA | Common Stock | D | 4,2840 | 1 183 | 5 | 430 600 | ||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | −167 000 | 7 839 750 | ||||||
| 2022-04-15 | 2021-04-14 | 4 | Harr Steve | SANA | Common Stock | D | −167 000 | 7 839 750 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 880 | 5 739 130 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | NELSEN ROBERT | SANA | Common Stock | D | 230 | 230 | ||||||
| 2022-03-22 | 2022-03-21 | 4 | Yang Patrick Y | SANA | Common Stock | D | 7,3000 | 28 000 | 204 | 174 250 | ||||
| 2022-03-08 | 2022-03-03 | 4 | Harr Steve | SANA | Stock Options (Right to Buy) | D | 5,70 | 760 000 | 760 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | AGARWAL SUNIL | SANA | Stock Options (Right to Buy) | D | 5,70 | 250 000 | 250 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Mulligan Richard | SANA | Stock Options (Right to Buy) | D | 5,70 | 250 000 | 250 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hordo Christian | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | MacDonald James J. | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-03-08 | 2022-03-03 | 4 | Hardy Nathan | SANA | Stock Options (Right to Buy) | D | 5,70 | 225 000 | 225 000 | |||||
| 2022-02-23 | 2022-02-18 | 4 | MacDonald James J. | SANA | Common Stock | D | 6,2800 | −333 | −2 | 429 417 | ||||
| 2022-02-23 | 2021-11-15 | 4 | MacDonald James J. | SANA | Common Stock | D | 18,2325 | 1 000 | 18 | 429 750 | ||||
| 2021-09-17 | 2021-09-16 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26,0000 | −1 627 | −42 | 1 550 000 | ||||
| 2021-09-17 | 2021-09-15 | 4 | AGARWAL SUNIL | SANA | Common Stock | D | 26,0695 | −58 373 | −1 522 | 1 551 627 | ||||
| 2021-09-14 | 2021-09-10 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0000 | −1 477 | −37 | 942 455 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | −39 205 | 88 803 | |||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0081 | −25 466 | −637 | 943 932 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0130 | −39 205 | −981 | 969 398 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 39 205 | 58 | 1 008 603 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | −700 | 128 008 | |||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0000 | −700 | −18 | 969 398 | ||||
| 2021-09-07 | 2021-09-03 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 700 | 1 | 970 098 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | −6 558 | 128 708 | |||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0039 | −1 400 | −35 | 969 398 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0019 | −6 558 | −164 | 970 798 | ||||
| 2021-09-07 | 2021-09-02 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 6 558 | 10 | 977 356 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | −1 134 | 135 266 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0057 | −3 002 | −75 | 970 798 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0036 | −1 134 | −28 | 973 800 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 1 134 | 2 | 974 934 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Stock Option (Right to Buy) | D | 1,48 | −1 100 | 136 400 | |||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0183 | −1 200 | −30 | 973 800 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 25,0100 | −1 100 | −28 | 975 000 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Hordo Christian | SANA | Common Stock | D | 1,4800 | 1 100 | 2 | 976 100 | ||||
| 2021-04-27 | 2021-04-21 | 4 | NELSEN ROBERT | SANA | Common Stock | I | 12 500 | 12 500 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | ARCH Venture Fund X, L.P. See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −11 585 199 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −11 441 326 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 725 122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −1 487 371 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11 585 199 | 11 585 199 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 11 441 326 | 11 441 326 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 9 725 122 | 9 725 122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Flagship Ventures Fund V General Partner LLC See footnotes | SANA | Common Stock | I | 1 487 371 | 1 487 371 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series B Convertible Preferred Stock | D | −156 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-2 Convertible Preferred Stock | D | −800 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Series A-1 Convertible Preferred Stock | D | −1 075 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Bishop Hans Edgar | SANA | Common Stock | D | 2 031 250 | 5 736 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | −2 343 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series B Convertible Preferred Stock | I | −781 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −5 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-2 Convertible Preferred Stock | I | −9 375 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Series A-1 Convertible Preferred Stock | I | −3 687 500 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 11 718 750 | 11 718 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 10 156 250 | 10 301 250 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Series A-2 Convertible Preferred Stock | I | −366 122 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Series A-2 Convertible Preferred Stock | D | −1 464 488 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT | SANA | Common Stock | I | 366 122 | 366 122 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | von Maltzahn Geoffrey | SANA | Common Stock | D | 1 464 488 | 1 464 488 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series B Convertible Preferred Stock | D | −156 250 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-2 Convertible Preferred Stock | D | −800 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Series A-1 Convertible Preferred Stock | D | −1 075 000 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | Harr Steve | SANA | Common Stock | D | 2 031 250 | 8 173 750 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Series B Convertible Preferred Stock | I | −7 812 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Series A-1 Convertible Preferred Stock | D | −93 750 | 0 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 | SANA | Common Stock | I | 7 812 | 7 812 | ||||||
| 2021-02-10 | 2021-02-08 | 4 | MacDonald James J. | SANA | Common Stock | D | 93 750 | 428 750 | ||||||
| 2021-02-05 | 2021-02-03 | 4 | NELSEN ROBERT | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | von Maltzahn Geoffrey | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bishop Hans Edgar | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | AGARWAL SUNIL | SANA | Stock Option (Right to Buy) | D | 25,00 | 48 000 | 48 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Bilenker Joshua H. | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Cole Douglas G. | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Wilderotter Mary Agnes | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Seitz Michelle | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | Yang Patrick Y | SANA | Stock Option (Right to Buy) | D | 25,00 | 14 000 | 14 000 | |||||
| 2021-02-05 | 2021-02-03 | 4 | REICIN ALISE | SANA | Stock Option (Right to Buy) | D | 25,00 | 7 000 | 7 000 | |||||
| 2021-02-03 | 3 | AGARWAL SUNIL | SANA | Common Stock | D | 1 610 000 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | NELSEN ROBERT See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | GILLIS STEVEN See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 145 000 | ||||||||
| 2021-02-03 | 3 | ARCH Venture Partners X, LLC See Footnotes | SANA | Common Stock | I | 147 500 | ||||||||
| 2021-02-03 | 3 | Hordo Christian | SANA | Common Stock | D | 975 000 | ||||||||
| 2021-02-03 | 3 | Yang Patrick Y | SANA | Common Stock | D | 146 250 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. | SANA | Common Stock | D | 335 000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the KOM Trust | SANA | Common Stock | I | 125 000 | ||||||||
| 2021-02-03 | 3 | MacDonald James J. Held by the NMM Trust | SANA | Common Stock | I | 125 000 | ||||||||
| 2021-02-03 | 3 | Mulligan Richard | SANA | Common Stock | D | 2 998 121 | ||||||||
| 2021-02-03 | 3 | Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 | SANA | Common Stock | I | 682 500 | ||||||||
| 2021-02-03 | 3 | Harr Steve | SANA | Common Stock | D | 6 142 500 | ||||||||
| 2021-02-03 | 3 | Bishop Hans Edgar | SANA | Common Stock | D | 3 705 000 | ||||||||
| 2021-02-03 | 3 | Hardy Nathan | SANA | Common Stock | D | 511 250 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
